ALCANZA INCLUSIVE CLINICAL RESEARCH

LIVE

Serial Number

97353268

Owner

Alcanza Clinical Research, LLC

Attorney

Mark A. Wright

First Use Date

Nov 30, 2023

Filing Date

Apr 8, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ALCANZA INCLUSIVE CLINICAL RESEARCH Trademark

Serial Number: 97353268 • Registration: 7311297

ALCANZA INCLUSIVE CLINICAL RESEARCH is a trademark filed by Alcanza Clinical Research, LLC on April 8, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Alcanza Clinical Research, LLC (26 trademarks)

615 Crescent Executive Court
Lake Mary, FL 32746

Entity Type: 16

Legal Representation

Attorney of Record

Mark A. Wright

2,182 trademarks filed View all →

Correspondence Address

Mark A. Wright MCLANE MIDDLETON, PROFESSIONAL ASSOCIATION

900 ELM STREET

P.O. BOX 326

MANCHESTER

NH 03105-0326

Trademark Details

Filing Date

April 8, 2022

Registration Date

February 20, 2024

First Use Anywhere

November 30, 2023

First Use in Commerce

November 30, 2023

Published for Opposition

April 11, 2023

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 20, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 20, 2024 R.PR

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 29, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 29, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 29, 2024 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 29, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 29, 2024 COAR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 17, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 16, 2024 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 20, 2023 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Dec 19, 2023 SUPC

SOU EXTENSION 1 GRANTED

Dec 19, 2023 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 19, 2023 AITU

USE AMENDMENT FILED

Nov 30, 2023 IUAF

SOU EXTENSION 1 FILED

Nov 30, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 30, 2023 EEXT

TEAS STATEMENT OF USE RECEIVED

Nov 30, 2023 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 6, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 11, 2023 NPUB

PUBLISHED FOR OPPOSITION

Apr 11, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 22, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 8, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 7, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 7, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 7, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 26, 2023 GNRN

NON-FINAL ACTION E-MAILED

Jan 26, 2023 GNRT

NON-FINAL ACTION WRITTEN

Jan 26, 2023 CNRT

ASSIGNED TO EXAMINER

Jan 26, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 12, 2022 NWOS

NEW APPLICATION ENTERED

Apr 12, 2022 NWAP

Related Trademarks

More from this Owner

FX CLINICAL RESEARCH

Serial #50030205

PHOENIX MEDICAL TRIALS

Serial #99796487

KCRI

More in Same Class

UAPX

ARCHMETA

VIA

WRITING A-Z

FOUNDATIONS A-Z